FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1987032859> ?p ?o ?g. }

• W1987032859 abstract "Background & Aims: Most GIST harbor oncogenic KIT or PDGFRA mutations, which are in most cases heterozygous. However, most GIST co-express both wild-type KIT and PDGFRA with the mutated KIT or PDGFRA. Signaling mediated by heterodimers of the wild-type receptors contribute to GIST growth even after blocking oncogenic signaling by KIT/PDGFRA inhibitors such as imatinib. Previously we found that crenolanib (CP-868596), a PDGFRA/B tyrosine kinase inhibitor with >100-fold selectivity over other tyrosine kinases including KIT and a potent inhibitor of oncogenic PDGFRA signaling in vitro, inhibited the proliferation of KIT + PDGFRA + PDGFRB − GIST-T1 cells with a potency comparable to that of imatinib (IC 50 : 5.3 nM; imatinib: IC 50 : 3.5 nM) but had very little effect in the KIT low/ − PDGFRA low/ − PDGFRB + GIST48B cells (maximum inhibition: 50 >75 nM) and in mouse stem cells for interstitial cells of Cajal (ICC-SC), a presumed cellular source for GIST, which share a phenotype with GIST48B cells (IC 50 >600 nM; Hayashi et al., Gastroenterology 2012; 142:S30). Here we investigated whether the antiproliferative effect of crenolanib was dependent on KIT expression, and studied crenolanib9s effect on KIT/PDGFRA signaling and on the stability of ETV1, a transcription factor required for GIST growth and survival. Methods: Protein expression and phosphorylation were studied by Western blotting. KIT low/ − PDGFRA low/+ PDGFRB + murine ICC-SC (2xSCS2F10) were retrovirally transduced to express wild-type murine KIT. Cell proliferation was studied by methyl-tetrazolium salt assay. Results: Expression of wild-type KIT in retrovirally transduced ICC-SC dramatically reduced crenolanib9s IC 50 from 1157 nM to 121 nM. In GIST-T1 cells, crenolanib significantly reduced PDGFRA and KIT protein expression, inhibited PDGFRA phosphorylation (IC 50 : 5 nM) but had no effect on KIT phosphorylation. Crenolanib applied at 8.3 nM concentration rapidly and profoundly inhibited phosphorylation of ERK1/2 MAP kinases and reduced ETV1 protein levels by >50% in 2 h. The MEK inhibitor PD98059 (50 μM) reproduced crenolanib9s effect on ETV1 protein levels with an identical time-course. The inhibitory effects of both crenolanib and PD98059 on ETV1 protein expression could be reversed with the proteasome inhibitor MG132 (10 μM) and accentuated with the protein synthesis inhibitor cycloheximide (10 μg/mL). ETV1 was undetectable in the crenolanib-resistant, KIT low/ − PDGFRA low/ − PDGFRB + GIST48B cells. Conclusions: In KIT mutant, KIT + PDGFRA + PDGFRB − GIST cells, crenolanib induced ETV1 protein degradation by suppressing PDGFRA-dependent MAPK phosphorylation. Crenolanib9s antiproliferative effect in these cells may depend on KIT-induced ETV1 expression and reflect the destabilization of ETV1. Grant support: NIH DK58185. Citation Format: Yujiro Hayashi, Michael R. Bardsley, Yoshitaka Toyomasu, Takahiro Taguchi, Brian P. Rubin, Monique Carter, Abhijit Ramachandran, Tamas Ordog. Crenolanib, a highly selective platelet-derived growth factor receptor α/β (PDGFRA/B) tyrosine kinase inhibitor, destabilizes ETV1 protein in KIT -mutant gastrointestinal stromal tumor (GIST) cells. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1035. doi:10.1158/1538-7445.AM2013-1035" @default.
• W1987032859 created "2016-06-24" @default.
• W1987032859 creator A5001267176 @default.
• W1987032859 creator A5028772847 @default.
• W1987032859 creator A5031123252 @default.
• W1987032859 creator A5046561483 @default.
• W1987032859 creator A5048425494 @default.
• W1987032859 creator A5082060300 @default.
• W1987032859 creator A5083995668 @default.
• W1987032859 creator A5089054370 @default.
• W1987032859 date "2013-04-15" @default.
• W1987032859 modified "2023-09-26" @default.
• W1987032859 title "Abstract 1035: Crenolanib, a highly selective platelet-derived growth factor receptor α/β (PDGFRA/B) tyrosine kinase inhibitor, destabilizes ETV1 protein inKIT-mutant gastrointestinal stromal tumor (GIST) cells." @default.
• W1987032859 doi "https://doi.org/10.1158/1538-7445.am2013-1035" @default.
• W1987032859 hasPublicationYear "2013" @default.
• W1987032859 type Work @default.
• W1987032859 sameAs 1987032859 @default.
• W1987032859 citedByCount "0" @default.
• W1987032859 crossrefType "proceedings-article" @default.
• W1987032859 hasAuthorship W1987032859A5001267176 @default.
• W1987032859 hasAuthorship W1987032859A5028772847 @default.
• W1987032859 hasAuthorship W1987032859A5031123252 @default.
• W1987032859 hasAuthorship W1987032859A5046561483 @default.
• W1987032859 hasAuthorship W1987032859A5048425494 @default.
• W1987032859 hasAuthorship W1987032859A5082060300 @default.
• W1987032859 hasAuthorship W1987032859A5083995668 @default.
• W1987032859 hasAuthorship W1987032859A5089054370 @default.
• W1987032859 hasConcept C101544691 @default.
• W1987032859 hasConcept C104317684 @default.
• W1987032859 hasConcept C121608353 @default.
• W1987032859 hasConcept C153911025 @default.
• W1987032859 hasConcept C16930146 @default.
• W1987032859 hasConcept C170493617 @default.
• W1987032859 hasConcept C180361614 @default.
• W1987032859 hasConcept C184235292 @default.
• W1987032859 hasConcept C185592680 @default.
• W1987032859 hasConcept C26375932 @default.
• W1987032859 hasConcept C2775922572 @default.
• W1987032859 hasConcept C2775960820 @default.
• W1987032859 hasConcept C2777583451 @default.
• W1987032859 hasConcept C2778729363 @default.
• W1987032859 hasConcept C2778820342 @default.
• W1987032859 hasConcept C2781249067 @default.
• W1987032859 hasConcept C3019892230 @default.
• W1987032859 hasConcept C37307934 @default.
• W1987032859 hasConcept C42362537 @default.
• W1987032859 hasConcept C502942594 @default.
• W1987032859 hasConcept C54355233 @default.
• W1987032859 hasConcept C55493867 @default.
• W1987032859 hasConcept C57074206 @default.
• W1987032859 hasConcept C62478195 @default.
• W1987032859 hasConcept C78221974 @default.
• W1987032859 hasConcept C86803240 @default.
• W1987032859 hasConcept C95444343 @default.
• W1987032859 hasConceptScore W1987032859C101544691 @default.
• W1987032859 hasConceptScore W1987032859C104317684 @default.
• W1987032859 hasConceptScore W1987032859C121608353 @default.
• W1987032859 hasConceptScore W1987032859C153911025 @default.
• W1987032859 hasConceptScore W1987032859C16930146 @default.
• W1987032859 hasConceptScore W1987032859C170493617 @default.
• W1987032859 hasConceptScore W1987032859C180361614 @default.
• W1987032859 hasConceptScore W1987032859C184235292 @default.
• W1987032859 hasConceptScore W1987032859C185592680 @default.
• W1987032859 hasConceptScore W1987032859C26375932 @default.
• W1987032859 hasConceptScore W1987032859C2775922572 @default.
• W1987032859 hasConceptScore W1987032859C2775960820 @default.
• W1987032859 hasConceptScore W1987032859C2777583451 @default.
• W1987032859 hasConceptScore W1987032859C2778729363 @default.
• W1987032859 hasConceptScore W1987032859C2778820342 @default.
• W1987032859 hasConceptScore W1987032859C2781249067 @default.
• W1987032859 hasConceptScore W1987032859C3019892230 @default.
• W1987032859 hasConceptScore W1987032859C37307934 @default.
• W1987032859 hasConceptScore W1987032859C42362537 @default.
• W1987032859 hasConceptScore W1987032859C502942594 @default.
• W1987032859 hasConceptScore W1987032859C54355233 @default.
• W1987032859 hasConceptScore W1987032859C55493867 @default.
• W1987032859 hasConceptScore W1987032859C57074206 @default.
• W1987032859 hasConceptScore W1987032859C62478195 @default.
• W1987032859 hasConceptScore W1987032859C78221974 @default.
• W1987032859 hasConceptScore W1987032859C86803240 @default.
• W1987032859 hasConceptScore W1987032859C95444343 @default.
• W1987032859 hasLocation W19870328591 @default.
• W1987032859 hasOpenAccess W1987032859 @default.
• W1987032859 hasPrimaryLocation W19870328591 @default.
• W1987032859 hasRelatedWork W1969530308 @default.
• W1987032859 hasRelatedWork W1995500704 @default.
• W1987032859 hasRelatedWork W1996537922 @default.
• W1987032859 hasRelatedWork W2024089671 @default.
• W1987032859 hasRelatedWork W2050564231 @default.
• W1987032859 hasRelatedWork W2064705161 @default.
• W1987032859 hasRelatedWork W2111032414 @default.
• W1987032859 hasRelatedWork W2139697097 @default.
• W1987032859 hasRelatedWork W2323109070 @default.
• W1987032859 hasRelatedWork W2503940741 @default.
• W1987032859 hasRelatedWork W2505742173 @default.
• W1987032859 hasRelatedWork W2516277994 @default.
• W1987032859 hasRelatedWork W2521399414 @default.
• W1987032859 hasRelatedWork W2557224541 @default.
• W1987032859 hasRelatedWork W2574884201 @default.
• W1987032859 hasRelatedWork W2580601526 @default.

• next